HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at ...

The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, it’s $44,000. The U.S. pays three times more for branded prescription drugs, on average, than other rich countries. It ...

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U ...

Medicare's new drug price negotiation program aims to save billions for the government and seniors. Starting in 2026, this ...

President Donald Trump said his executive order on drug prices would lower some prices in half or more. But the details are ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

From sweeping drug price reforms to proposed staffing mandates and changes to Medicaid financing, here are five federal policy moves from the last week that ASCs need to know: CMS proposes updates for ...

The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Currently, Medicare has to wait seven years after a traditional drug gets approved by the U.S. Food and Drug Administration (FDA) before it’s eligible for Medicare price negotia ...